Primoris Services Corporation (NYSE:PRIM) experienced a significant stock price decline following missed financial forecasts and reduced Adjusted EBITDA guidance. Analyst firm Needham set an ...
Clinical trial failures significantly impacted bi...
Corporate events, including significant financing...
Analyst firm Jefferies maintained a "Buy" rating for Biogen, signaling confidence in the biotechnology stock. The U.S. FDA approval of an at-home starting dose for LEQEMBI enhances patient co
Bank of America (NYSE: BAC) is set to release its quarterly earnings report on July 14, 2026, amidst a busy week for the banking sector, with competitors like JPMorgan Chase & Co (NYSE: JPM) and
Wells Fargo & Company (NYSE:WFC) demonstrates stable financial performance and optimistic analyst sentiment ahead of its Q2 2026 earnings release. The broader banking sector is experiencing f
Ball Corporation is a global leader in sustainable aluminum packaging and aerospace, showcasing diversified operations. Despite a recent minor pullback, the stock has demonstrated solid month
Jefferies raised its price target for Tesla (NASDAQ: TSLA) to $400.00 from $375.00, citing strong delivery numbers. Despite the increased target, Jefferies maintained a "Hold" rating, with Te
Alnylam Pharmaceuticals (NASDAQ: ALNY) Surges on Analyst Upgrade and Robust Pipeline Growth Analyst Confidence Soars: H.C. Wainwright significantly raised its price target for Alnylam Pharmaceuticals
